Potassium saving diuretics

Last updated on: 21.07.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Potassium-sparing diuretics are an (inhomogeneous) group of drugs that affect the Na+ channel in the luminal membrane of the late distal tubule and collecting duct at the nephron, increasing Na+ ions and water and decreasing K+ ions excreted in the urine. Although pharmacologically different in structure, they share a common functional site and that is the mineral corticoid receptors.

ClassificationThis section has been translated automatically.

The so-called potassium-saving diuretics include the organic cations

and the aldosterone antagonists

The orally available drugs amiloride and triamterene are only available in Germany as combination preparations with hydrochlorothiazide (e.g. Dytide®, Moduretik®). In cases of severe hepatic or nephrotic edema, they are used together with loop diuretics.

The aldosterone antagonists spironolactone and eplerenone are not primarily used as antidiuretics but for the treatment of chronic heart failure. Their diuretic effect is not in the foreground here.

Pharmacodynamics (Effect)This section has been translated automatically.

In the late distal tubule and collecting duct, an epithelial Na+ channel provides electrogenic Na+ uptake into the principal cells of this tubular segment. Amiloride and triamterene block this Na+ channel, with amiloride acting 10xpotently than triamterene. Blockade of this channel leads to an increase in Na+ excretion to 2-4% of filtered Na+. This process leads to hyperpolarization of the luminal cell membrane with the consequence that the luminal negative transepithelial potential is reduced. As a result, tubular K+ secretion decreases markedly. The reduction of the luminal trnasepithelial potential is also responsible for the decreased renal excretion of H+, Ca2+ and Mg2+.

IndicationThis section has been translated automatically.

Potassium-sparing diuretics are usually used in combination with a thiazide diuretic for the treatment of arterial hypertension. This is to prevent hypokalemia under thiazides. Unlike a thiazide diuretic and a loop diuretic, a potassium-sparing diuretic can also be combined with a cardiac glycoside.

Other indications:

Oedema of cardiac, renal and hepatic origin (when reduced potassium excretion is desired).

Undesirable effectsThis section has been translated automatically.

Adverse reactions: see below the individual substances.

ADRs mainly concern the electrolyte balance, in this case hyperkalaemia with bradycardic cardiac arrhythmias. Use together with ACE inhibitors, sartans and potassium preparations should be avoided. Occasionally, therapy with potassium-sparing diuretics may lead to non-specific gastrointestinal side effects (nausea, vomiting, diarrhoea).

Other potential side effects include:

  • metabolic acidosis
  • fatigue, dizziness
  • Muscle cramps
  • skin exanthema
  • Phototoxicity
  • Triamterene may also impair glucose tolerance; furthermore, the drug is contraindicated in diseases with possible folic acid deficiency (liver cirrhosis, alcoholism) (Graefe KH 2016).

InteractionsThis section has been translated automatically.

See below the individual preparations

ContraindicationThis section has been translated automatically.

severe hepatic impairment

Hypovolemia

Hyponatremia

Hyperkalemia

Folic acid deficiency

Last updated on: 21.07.2021